Livzon Pharmaceutical Group Inc. (1513.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 22.88B |
| Enterprise Value | 17.42B |
| P/E Ratio | 13.28 |
| PEG Ratio | -4.35 |
| Price/Sales Ratio | 2.24 |
| Price/Book Ratio | 1.8 |
| Enterprise/Revenue | 1.8 |
| Enterprise/EBITDA | 6.82 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.17 |
| Operating Margin | 0.23 |
AD
Management Effectiveness
| Return On Assets | 0.08 |
| Return On Equity | 0.14 |
Income Statement
| Revenue | 12.02B |
| Revenue/Share | 13.19 |
| Gross Profit | 7.92B |
| EBITDA | 3.1B |
| Net Income | 2.02B |
| Diluted EPS | 2.27 |
Balance Sheet
| Total Cash | 9.56B |
| Total Cash/Share | 10.81 |
| Total Debt | 2.89B |
| Total Debt/Equity | 0.26 |
| Current Ratio | 1.96 |
| Book Value Per Share | 17.56 |
Price History
| 52-Week Change | -17.7 |
| 52-Week High | 41.85 |
| 52-Week Low | 23.66 |
| Moving Average 50 Days | 27.31 |
| Moving Average 200 Days | 29.93 |
Statistics
| Average Volume | 977,072 |
| Shares Outstanding | 1.09B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 1.43 |
| Trailing Annual Dividend Yield | 4.85 |
| Payout Ratio | 0.85 |
| Last Split Factor | 13:10 |
| Last Split Date | July 03, 2019 |
AD
